Acting upon V2 receptors expressed in the kidney, AVP appears to contribute to the progression of chronic kidney disease and decline in glomerular filtration rate [29, 30] and may be involved in the progression of autosomal dominant polycystic kidney disease (ADPKD) [32]. The gene discussed is AVP; the disease is chronic kidney disease.